Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | EVP & President-CVS/pharmacy | September 30, 2013 | October 01, 2013 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date September 30, 2013 · Filed October 01, 2013
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,955 |
Ending reported balance
After 2013-09-30 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2013-09-30 · Exercise / conversion · Acquired 115,006 · Balance 187,849 Row 2 · 2013-09-30 · Sale · Disposed 115,006 · Balance 72,843 F1: All sales were effected pursuant to a Rule 10b5-1 plan. F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $57.20 and $57.58 per share. Row 3 · 2013-09-30 · Sale · Disposed 26,888 · Balance 45,955 F1: All sales were effected pursuant to a Rule 10b5-1 plan. F3: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $57.22 and $57.55 per share. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $35.78 · Expires 2018-09-01 | Direct | 57,503 |
Reported balance
After 2013-09-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2013-09-30 · Exercise / conversion · Disposed 115,006 · Balance 57,503 F4: Option became exercisable in three equal installments, commencing 9/1/2012. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $45.07 · Expires 2019-04-02 | Direct | 66,548 |
Reported balance
Holding disclosure · report date 2013-09-30 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 66,548 F5: Option became exercisable in four equal annual installments, commencing 4/2/2013. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.53 · Expires 2020-04-01 | Direct | 59,009 |
Reported balance
Holding disclosure · report date 2013-09-30 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 59,009 F6: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 30,395 |
Reported balance
Holding disclosure · report date 2013-09-30 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 30,395 |
Filing footnotes · ownership attribution and instrument terms
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $57.20 and $57.58 per share.
F3: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $57.22 and $57.55 per share.
F4: Option became exercisable in three equal installments, commencing 9/1/2012.
F5: Option became exercisable in four equal annual installments, commencing 4/2/2013.
F6: Option becomes exercisable in four equal annual installments, commencing 4/1/2014.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Michaels Companies, Inc.
Report date April 15, 2021 · Filed April 19, 2021
Section 16 reporting ended · disclosed 2021-04-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2021-04-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-04-15 · Other · Disposed 133,933 · Balance 17,992 F1: Pursuant to the terms of the Merger Agreement, these shares of the Issuer's common stock were tendered and disposed of at the Acceptance Time in exchange for the right to receive $22.00 per share of common stock, net to the seller, in cash, without interest and less any applicable withholding taxes (the "Merger Consideration"). Row 2 · 2021-04-15 · Disposition to issuer · Disposed 17,992 · Balance 0 F2: Represents shares of the Issuer's common stock granted subject to vesting or other lapse restrictions that were outstanding immediately prior to the Effective Time and that, pursuant to the Merger Agreement, vested in full and became free of such restrictions as of the Effective Time and were converted into the right to receive the Merger Consideration. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $9.87 | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-04-15 · Disposition to issuer · Disposed 860,000 · Balance 0 F3: Pursuant to the Merger Agreement, at or immediately prior to the Effective Time, each option to purchase shares of the Issuer's common stock (each, a "Stock Option") that had an exercise price per share underlying such option that is less than the Merger Consideration (each, an "In-the-Money Stock Option"), whether or not exercisable or vested, was automatically cancelled, by virtue of the Merger, without any action on the part of the Reporting Person, and the Reporting Person was entitled to receive an amount in cash equal to (a) the amount by which the Merger Consideration exceeds the applicable exercise price per share underlying such In-the-Money Stock Option multiplied by (b) the number of shares subject to such In-the-Money Stock Option. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-04-15 · Disposition to issuer · Disposed 37,500 · Balance 0 F4: Pursuant to the Merger Agreement, at or immediately prior to the Effective Time, each award of restricted stock units with respect to shares of the Issuer's common stock subject to vesting based solely on continued employment or service to the Issuer or any of its subsidiaries (each, a "Restricted Stock Unit") that was then outstanding was cancelled and converted into the right to receive an amount in cash equal to (a) the number of shares subject to such Restricted Stock Unit immediately prior to the Effective Time multiplied by (b) the Merger Consideration. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-04-15 · Disposition to issuer · Disposed 15,219 · Balance 0 F4: Pursuant to the Merger Agreement, at or immediately prior to the Effective Time, each award of restricted stock units with respect to shares of the Issuer's common stock subject to vesting based solely on continued employment or service to the Issuer or any of its subsidiaries (each, a "Restricted Stock Unit") that was then outstanding was cancelled and converted into the right to receive an amount in cash equal to (a) the number of shares subject to such Restricted Stock Unit immediately prior to the Effective Time multiplied by (b) the Merger Consideration. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-04-15 · Disposition to issuer · Disposed 37,500 · Balance 0 F4: Pursuant to the Merger Agreement, at or immediately prior to the Effective Time, each award of restricted stock units with respect to shares of the Issuer's common stock subject to vesting based solely on continued employment or service to the Issuer or any of its subsidiaries (each, a "Restricted Stock Unit") that was then outstanding was cancelled and converted into the right to receive an amount in cash equal to (a) the number of shares subject to such Restricted Stock Unit immediately prior to the Effective Time multiplied by (b) the Merger Consideration. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-04-15 · Disposition to issuer · Disposed 5,280 · Balance 0 F4: Pursuant to the Merger Agreement, at or immediately prior to the Effective Time, each award of restricted stock units with respect to shares of the Issuer's common stock subject to vesting based solely on continued employment or service to the Issuer or any of its subsidiaries (each, a "Restricted Stock Unit") that was then outstanding was cancelled and converted into the right to receive an amount in cash equal to (a) the number of shares subject to such Restricted Stock Unit immediately prior to the Effective Time multiplied by (b) the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of the Merger Agreement, these shares of the Issuer's common stock were tendered and disposed of at the Acceptance Time in exchange for the right to receive $22.00 per share of common stock, net to the seller, in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").
F2: Represents shares of the Issuer's common stock granted subject to vesting or other lapse restrictions that were outstanding immediately prior to the Effective Time and that, pursuant to the Merger Agreement, vested in full and became free of such restrictions as of the Effective Time and were converted into the right to receive the Merger Consideration.
F3: Pursuant to the Merger Agreement, at or immediately prior to the Effective Time, each option to purchase shares of the Issuer's common stock (each, a "Stock Option") that had an exercise price per share underlying such option that is less than the Merger Consideration (each, an "In-the-Money Stock Option"), whether or not exercisable or vested, was automatically cancelled, by virtue of the Merger, without any action on the part of the Reporting Person, and the Reporting Person was entitled to receive an amount in cash equal to (a) the amount by which the Merger Consideration exceeds the applicable exercise price per share underlying such In-the-Money Stock Option multiplied by (b) the number of shares subject to such In-the-Money Stock Option.
F4: Pursuant to the Merger Agreement, at or immediately prior to the Effective Time, each award of restricted stock units with respect to shares of the Issuer's common stock subject to vesting based solely on continued employment or service to the Issuer or any of its subsidiaries (each, a "Restricted Stock Unit") that was then outstanding was cancelled and converted into the right to receive an amount in cash equal to (a) the number of shares subject to such Restricted Stock Unit immediately prior to the Effective Time multiplied by (b) the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 21, 2019 Filed Oct 23, 2019 17:02 UTC | Michaels Companies, Inc. MIK · Entity 15760 | GrantEmployee Stock Options (right to buy) · Derivative | 860,000 | $0.00 Strike: $9.87 | $0.00 |
DisclosureSEC source: 0001179110-19-011207 · edgar.xml · derivative · entry 1 COSBY MARK · CIK 0001214180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 860,000 Underlying: Common Stock · 860,000 shares Expires 2029-10-20 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on October 21, 2020, the first anniversary of the grant date. Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 21:10 UTC | Michaels Companies, Inc. MIK · Entity 15760 | Tax withholdingCommon Stock | 696 | $5.42 | $3,772.32 |
DisclosureSEC source: 0001179110-19-009970 · edgar.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,970 F1 · kind: Withholding of common stock to satisfy reporting person's tax obligation upon the restriction lapse of a restricted stock award. Read SEC document |
| August 05, 2019 Filed Aug 6, 2019 16:43 UTC | Michaels Companies, Inc. MIK · Entity 15760 | GrantCommon Stock | 55,310 | $6.78 | $375,001.80 |
DisclosureSEC source: 0001179110-19-009213 · edgar.xml · nonDerivative · entry 2 COSBY MARK · CIK 0001214180 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,666 Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 16:43 UTC | Michaels Companies, Inc. MIK · Entity 15760 | Tax withholdingCommon Stock | 1,225 | $6.76 | $8,281.00 |
DisclosureSEC source: 0001179110-19-009213 · edgar.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,356 F1 · kind: Withholding of common stock to satisfy reporting person's tax obligation upon the restriction lapse of a restricted stock award. Read SEC document |
| May 28, 2019 Filed May 30, 2019 17:36 UTC | Michaels Companies, Inc. MIK · Entity 15760 | Tax withholdingCommon Stock | 695 | $9.29 | $6,456.55 |
DisclosureSEC source: 0001179110-19-006864 · edgar.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,581 F1 · kind: Withholding of common stock to satisfy reporting person's tax obligation upon the restriction lapse of a restricted stock award. Read SEC document |
| May 06, 2019 Filed May 7, 2019 19:07 UTC | Michaels Companies, Inc. MIK · Entity 15760 | GrantCommon Stock | 33,333 | $11.25 | $374,996.25 |
DisclosureSEC source: 0001179110-19-005688 · edgar.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,276 Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 18:27 UTC | Michaels Companies, Inc. MIK · Entity 15760 | GrantCommon Stock | 18,943 | $14.14 | $267,854.02 |
DisclosureSEC source: 0001179110-19-003137 · edgar.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,943 Read SEC document |
| September 30, 2013 Filed Oct 1, 2013 20:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 115,006 | $0.00 Strike: $35.78 | $0.00 |
DisclosureSEC source: 0001127602-13-028171 · form4.xml · derivative · entry 5 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,503 Underlying: Common Stock · 115,006 shares Expires 2018-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three equal installments, commencing 9/1/2012. Read SEC document |
| September 30, 2013 Filed Oct 1, 2013 20:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 26,888 | $57.37 | $1,542,685.56 |
DisclosureSEC source: 0001127602-13-028171 · form4.xml · nonDerivative · entry 3 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,955 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $57.22 and $57.55 per share. Read SEC document |
| September 30, 2013 Filed Oct 1, 2013 20:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 115,006 | $57.38 | $6,598,503.75 |
DisclosureSEC source: 0001127602-13-028171 · form4.xml · nonDerivative · entry 2 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,843 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $57.20 and $57.58 per share. Read SEC document |
| September 30, 2013 Filed Oct 1, 2013 20:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 115,006 | $35.78 | $4,114,914.68 |
DisclosureSEC source: 0001127602-13-028171 · form4.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2013 Filed Sep 3, 2013 19:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 20,098 | $58.05 | $1,166,688.90 |
DisclosureSEC source: 0001127602-13-026437 · form4.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,843 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 59,009 | $54.53 Strike: $54.53 | $3,217,760.77 |
DisclosureSEC source: 0001127602-13-013261 · form4.xml · derivative · entry 3 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,009 Underlying: Common Stock · 59,009 shares Expires 2020-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 13,754 | $54.53 | $750,005.62 |
DisclosureSEC source: 0001127602-13-013261 · form4.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,318 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| September 01, 2012 Filed Sep 4, 2012 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 17,793 | $45.55 | $810,471.15 |
DisclosureSEC source: 0001127602-12-025632 · form4.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,018 F1 · kind: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 66,548 | $45.07 Strike: $45.07 | $2,999,318.36 |
DisclosureSEC source: 0001127602-12-013298 · form4.xml · derivative · entry 3 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,548 Underlying: Common Stock · 66,548 shares Expires 2019-04-02 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 16,641 | $45.07 | $750,009.87 |
DisclosureSEC source: 0001127602-12-013298 · form4.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,487 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| September 01, 2011 Filed Sep 6, 2011 20:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 172,509 | $35.78 Strike: $35.78 | $6,172,372.02 |
DisclosureSEC source: 0001127602-11-024803 · form4.xml · derivative · entry 3 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,509 Underlying: Common Stock · 172,509 shares Expires 2018-09-01 F3 · derivative.exercise_date: Option becomes exercisable in three equal installments, commencing 9/1/2012. Read SEC document |
| September 01, 2011 Filed Sep 6, 2011 20:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 15,035 | $35.78 | $537,952.30 |
DisclosureSEC source: 0001127602-11-024803 · form4.xml · nonDerivative · entry 2 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,888 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| September 01, 2011 Filed Sep 6, 2011 20:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 125,769 | $35.78 | $4,500,014.82 |
DisclosureSEC source: 0001127602-11-024803 · form4.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,846 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 9/1/2011. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.